Please assess the completion status of the following clinical trial:

Trial Title: CPT-3 in Normal Pressure Hydrocephalus

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* patients being referred for CSF tap test as part of routine clinical assessment of idiopathic Normal Pressure Hydrocephalus by their medical provider~* adults older than 18 years old~Exclusion Criteria:~* premorbid neurodegenerative disease (e.g. Alzheimer's Disease, Frontotemproal Dementia, Parkinson's Disease)~* serious acquired brain injury such as moderate to severe traumatic brain injury, large ischemic strokes~* seizure disorders~* serious neuropsychiatric disease (e.g. schizophrenia, bipolar disorder, major depressive disorder, active alcohol or drug abuse)~* untreated vitamin deficiencies (B12, Wernicke-Korsakoff Syndrome)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).